Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care
نویسندگان
چکیده
منابع مشابه
Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.
Peritoneal carcinomatosis (PC) is one manifestation of metastatic colorectal cancer (CRC). Tumor growth on intestinal surfaces and associated fluid accumulation eventually result in bowel obstruction and incapacitating levels of ascites, which profoundly affect the quality of life for affected patients. PC appears resistant to traditional 5-fluorouracil-based chemotherapy, and surgery was forme...
متن کاملTreatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy
BACKGROUND Diagnosis of peritoneal carcinomatosis (PC) may be missed by preoperative imaging. We are presenting our experience with incidentally detected PC of colorectal origin treated with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) at the same operation. METHODS Between January 2010 and September 2016, 19 patients underwent CRS and IPC due to incidentally detected PC...
متن کاملSystemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin.
Combining chemotherapy and targeted therapies has resulted in an enhanced survival in metastatic colorectal cancer (mCRC) patients. However, the result of this palliative treatment in patients with metachronous peritoneal carcinomatosis (PC) remains unknown. The current population-based study aims to investigate the use and effect of palliative systemic treatment in patients with metachronous P...
متن کاملPeritoneal carcinomatosis of colorectal origin Is there a role for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
Siham Zerhouni, MD is a surgical resident with the Department of Surgery, University of British Columbia, Vancouver, and a graduate student in the Division of Experimental Therapeutics, Toronto General Research Institute and Institute of Medical Science, University of Toronto. J. Andrea McCart, MD, MSc, FRCSC is the Director of the Ontario Peritoneal Malignancy Program; associate Professor in t...
متن کاملModern management of peritoneal carcinomatosis of colorectal origin – Is hyperthermic intraoperative peritoneal chemotherapy the treatment of first choice?
Although cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is still considered as “experimental” by many, there is growing evidence that supports its general use in selective patients with peritoneal carcinomatosis of colorectal origin. The selection of patients remains challenging but is the crucial key to achieve optimal oncological results. Recent st...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Surgery
سال: 2006
ISSN: 0003-4932
DOI: 10.1097/01.sla.0000239629.96036.cd